Short communication-Lessons learnt during the implementation of Unity-aligned SARS-CoV-2 seroprevalence studies in Africa
© 2023 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd..
The WHO Unity Studies initiative engaged low- and middle-income countries in the implementation of standardised SARS-CoV-2 sero-epidemiological investigation protocols and timely sharing of comparable results for evidence-based action. To gain a deeper understanding of the methodological challenges faced when conducting seroprevalence studies in the African region, we conducted unstructured interviews with key study teams in five countries. We discuss the challenges identified: participant recruitment and retention, sampling, sample and data management, data analysis and presentation. Potential solutions to aid future implementation include preparedness actions such as the development of new tools, robust planning and practice.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
Influenza and other respiratory viruses - 17(2023), 8 vom: 23. Aug., Seite e13170 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Farley, Elise [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Completed 28.08.2023 Date Revised 14.12.2023 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.1111/irv.13170 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361201761 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361201761 | ||
| 003 | DE-627 | ||
| 005 | 20231227131512.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/irv.13170 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1225.xml |
| 035 | |a (DE-627)NLM361201761 | ||
| 035 | |a (NLM)37621920 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Farley, Elise |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Short communication-Lessons learnt during the implementation of Unity-aligned SARS-CoV-2 seroprevalence studies in Africa |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.08.2023 | ||
| 500 | |a Date Revised 14.12.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd. | ||
| 520 | |a The WHO Unity Studies initiative engaged low- and middle-income countries in the implementation of standardised SARS-CoV-2 sero-epidemiological investigation protocols and timely sharing of comparable results for evidence-based action. To gain a deeper understanding of the methodological challenges faced when conducting seroprevalence studies in the African region, we conducted unstructured interviews with key study teams in five countries. We discuss the challenges identified: participant recruitment and retention, sampling, sample and data management, data analysis and presentation. Potential solutions to aid future implementation include preparedness actions such as the development of new tools, robust planning and practice | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a SARS‐CoV‐2 | |
| 650 | 4 | |a Unity Studies | |
| 650 | 4 | |a methodological challenges | |
| 650 | 4 | |a sero‐epidemiological investigations | |
| 700 | 1 | |a Okeibunor, Joseph |e verfasserin |4 aut | |
| 700 | 1 | |a Balde, Thierno |e verfasserin |4 aut | |
| 700 | 1 | |a Donkor, Irene Owusu |e verfasserin |4 aut | |
| 700 | 1 | |a Kleynhans, Jackie |e verfasserin |4 aut | |
| 700 | 1 | |a Wamala, Joseph Francis |e verfasserin |4 aut | |
| 700 | 1 | |a Kaboré, Nongodo Firmin |e verfasserin |4 aut | |
| 700 | 1 | |a Balam, Saidou |e verfasserin |4 aut | |
| 700 | 1 | |a Chamla, Dick |e verfasserin |4 aut | |
| 700 | 1 | |a Braka, Fiona |e verfasserin |4 aut | |
| 700 | 1 | |a Subissi, Lorenzo |e verfasserin |4 aut | |
| 700 | 1 | |a Herring, Belinda |e verfasserin |4 aut | |
| 700 | 1 | |a Whelan, Mairead G |e verfasserin |4 aut | |
| 700 | 1 | |a Bergeri, Isabel |e verfasserin |4 aut | |
| 700 | 1 | |a Lewis, Hannah C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Influenza and other respiratory viruses |d 2007 |g 17(2023), 8 vom: 23. Aug., Seite e13170 |w (DE-627)NLM176605215 |x 1750-2659 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2023 |g number:8 |g day:23 |g month:08 |g pages:e13170 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/irv.13170 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2023 |e 8 |b 23 |c 08 |h e13170 | ||